Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Vanda Pharmaceuticals Inc.    VNDA   US9216591084

 SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
12/11/2014 12/12/2014 12/15/2014 12/16/2014 12/17/2014 Date
12.89(c) 12.72(c) 12.45(c) 12.44(c) 12.81(c) Last
1 026 013 351 917 613 710 365 943 608 231 Volume
+1.90% -1.32% -2.12% -0.08% +2.97% Change
More quotes
Company
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders.Its product portfolio includes Fanapt and Tasimelteon.The Fanapt product is a compound for the treatment of schizophrenia, the... 
More about the company
Surperformance© ratings of Vanda Pharmaceuticals Inc.
Trading Rating : Investor Rating :
More Ratings
Chart VANDA PHARMACEUTICALS INC.
Duration : Period :
Vanda Pharmaceuticals Inc. Technical Analysis Chart | VNDA | US9216591084 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 51,2 M
EBIT 2014 -57,4 M
Net income 2014 -57,8 M
Debt 2014 -
Yield 2014 -
Sales 2015 90,6 M
EBIT 2015 -26,2 M
Net income 2015 -41,5 M
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 9,91x
Capi. / Sales 2015 5,61x
Capitalization 508 M
More Financials
Latest news on VANDA PHARMACEUTICALS INC.
12/05 VANDA PHARMACEUTICALS : Change in Directors or Principal Officers (form 8-K)
12/01 VANDA PHARMACEUTICALS : to Present at the 26th Annual Piper Jaffray Healthcare C..
11/26 VANDA PHARMACEUTICALS : to Present at the Stifel Nicolaus 2014 Healthcare Confer..
11/18 VANDA PHARMACEUTICALS : to Present at the Stifel Nicolaus 2014 Healthcare Confer..
11/03 VANDA PHARMACEUTICALS : Other Events (form 8-K)
10/31 VANDA PHARMACEUTICALS : U.S. Patents Awarded to Inventors in Kansas (Oct. 31)
10/31 VANDA PHARMACEUTICALS : Assigned Patent
10/31 VANDA PHARMACEUTICALS : Assigned Patent
More news
Sector news
1d ago MEDIVATION : Announces Participation at Upcoming Investor Conference
1d ago QUINTILES TRANSNATIONAL : CEO Tom Pike to Present at J.P. Morgan Healthcare Conf..
1d agoDJUnited Therapeutics Cuts Top Executive's Pay, Names Co-Chief
More sector news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF